Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
Citations Over TimeTop 10% of 2018 papers
Abstract
The chronic skin inflammation psoriasis is crucially dependent on the IL-23/IL-17 cytokine axis. Although IL-23 is expressed by psoriatic keratinocytes and immune cells, only the immune cell-derived IL-23 is believed to be disease relevant. Here we use a genetic mouse model to show that keratinocyte-produced IL-23 is sufficient to cause a chronic skin inflammation with an IL-17 profile. Furthermore, we reveal a cell-autonomous nuclear function for the actin polymerizing molecule N-WASP, which controls IL-23 expression in keratinocytes by regulating the degradation of the histone methyltransferases G9a and GLP, and H3K9 dimethylation of the IL-23 promoter. This mechanism mediates the induction of IL-23 by TNF, a known inducer of IL-23 in psoriasis. Finally, in keratinocytes of psoriatic lesions a decrease in H3K9 dimethylation correlates with increased IL-23 expression, suggesting relevance for disease. Taken together, our data describe a molecular pathway where epigenetic regulation of keratinocytes can contribute to chronic skin inflammation.
Related Papers
- → Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a(2014)185 cited
- → Transcriptional regulation by methyltransferases and their role in the heart: highlighting novel emerging functionality(2020)17 cited
- → Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors(2007)56 cited
- → INTERLEUKIN 23 AND INTERLEUKIN17 IN PSORIASIS, ATOPIC DERMATITIS AND LICHEN PLANUS: A SEROLOGICAL STUDY(2015)3 cited
- → Biological agents targeting interleukin-23/Th17 axis in inflammatory skin diseases: from basic research to clinical application(2022)1 cited